Worldquant Millennium Advisors LLC Sells 23,001 Shares of STERIS plc (NYSE:STE)

Worldquant Millennium Advisors LLC lowered its stake in STERIS plc (NYSE:STE) by 73.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 8,222 shares of the medical equipment provider’s stock after selling 23,001 shares during the period. Worldquant Millennium Advisors LLC’s holdings in STERIS were worth $1,690,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in STE. Avalon Trust Co bought a new stake in STERIS in the fourth quarter valued at $30,000. Human Investing LLC purchased a new position in STERIS during the fourth quarter valued at $31,000. Anfield Capital Management LLC lifted its position in STERIS by 100.0% during the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock valued at $37,000 after buying an additional 91 shares during the period. Manchester Capital Management LLC lifted its position in STERIS by 182.7% during the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock valued at $44,000 after buying an additional 137 shares during the period. Finally, Brown Brothers Harriman & Co. lifted its position in STERIS by 66.7% during the fourth quarter. Brown Brothers Harriman & Co. now owns 220 shares of the medical equipment provider’s stock valued at $45,000 after buying an additional 88 shares during the period. Institutional investors own 94.69% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have commented on STE. Piper Sandler raised their price objective on STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a research report on Monday, February 3rd. Wall Street Zen raised STERIS from a “buy” rating to a “strong-buy” rating in a research report on Thursday. Citigroup reissued an “outperform” rating on shares of STERIS in a research report on Friday, May 16th. Needham & Company LLC reissued a “hold” rating on shares of STERIS in a research report on Monday, April 7th. Finally, Stephens reissued an “overweight” rating and set a $250.00 price objective on shares of STERIS in a research report on Thursday, May 15th. Two analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $264.00.

STERIS Price Performance

Shares of NYSE:STE opened at $243.61 on Friday. STERIS plc has a 1-year low of $200.98 and a 1-year high of $252.79. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.13 and a quick ratio of 1.40. The business has a fifty day moving average price of $225.95 and a 200-day moving average price of $220.00. The company has a market capitalization of $23.93 billion, a PE ratio of 51.72 and a beta of 0.96.

STERIS (NYSE:STE) last issued its quarterly earnings results on Wednesday, May 14th. The medical equipment provider reported $2.74 earnings per share for the quarter, beating the consensus estimate of $2.59 by $0.15. STERIS had a return on equity of 13.91% and a net margin of 8.66%. The firm had revenue of $1.48 billion during the quarter, compared to the consensus estimate of $1.47 billion. During the same period last year, the company earned $2.58 earnings per share. The company’s revenue was up 5.7% on a year-over-year basis. As a group, equities analysts expect that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 26th. Investors of record on Tuesday, June 10th will be issued a $0.57 dividend. The ex-dividend date of this dividend is Tuesday, June 10th. This represents a $2.28 annualized dividend and a yield of 0.94%. STERIS’s payout ratio is 36.77%.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.